Companies in
Pharmaceutical Industry

VITA24 AG

Pharmaceutical Industry · Rebstein · Since 2017

VITA24 AG operates an online shop offering dietary supplements, health products and self-tests. The assortment includes categories such as basic nutrition, nervous system & mental health, immune support and muscle care, and the company provides order fulfilment and customer support.

Swizzard Pharma AG

Pharmaceutical Industry · Zug · Since 2020

The core activity of Swizzard Pharma AG is to support companies in introducing medical products to the Swiss market. To this end, Swizzard offers a wide range of services, including market entry strategies, regulatory support, market access, product launch and distribution strategies. The company supports its customers in successfully introducing products to the Swiss market and helps them to turn their medical breakthroughs into innovative products that benefit patients in Switzerland.

Swyssi PMFS AG

Pharmaceutical Industry · Bäch Sz · Since 2000

The core activity of Swyssi is the development and manufacture of complex generic drugs, as well as the life cycle extension of established, off-patent medicines, particularly in the areas of cardiology, diabetes, central nervous system and respiratory diseases.

Synendos Therapeutics AG

Research & Development · Basel · Since 2019

The core activity of Synendos Therapeutics AG is the development of pharmaceuticals, particularly the research and development of active ingredients and medicines in various therapeutic areas, including clinical trials and approval. The company focuses on the development of medicines for various diseases, including neurological disorders, and offers services in the fields of medicinal chemistry, pharmacology, clinical research and development.

Synnergan Sàrl

Cosmetics Industry · Geneva · Since 2021

The core activity of Synnergan is the development and manufacture of patented dietary supplements, particularly in the areas of fat loss and muscle building. These products are manufactured in Switzerland and are based on scientific findings and research results.

SynphaBase AG

Chemical Industry · Pratteln · Since 2000

The core activity of SynphaBase AG is the development and implementation of processes for the synthesis of complex organic compounds, particularly in the fields of medicinal chemistry, carbohydrate chemistry and process research and development. The company offers services such as laboratory synthesis, synthesis route development, process development and the production of organic and bioactive molecules.

SYRHATECH SA

Pharmaceutical Industry · Plan-Les-Ouates · Since 2015

Syrhatech SA is a Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of formulations for the cosmetics and pharmaceutical industries. The core activities include research and development (R&D), formulation, manufacturing and analysis of products. The company also offers technology transfer and batch manufacturing for clients.

T3 Pharmaceuticals AG

Pharmaceutical Industry · Allschwil · Since 2015

The core activity of T3 Pharmaceuticals AG is the development of anti-cancer drugs, particularly through the research and development of innovative therapeutics based on microbial pathogenesis and immunotherapy. The company focuses on the discovery and development of new active substances (NCEs) and the clinical development of targeted therapeutics, especially in the fields of oncology and hematology.

Taiho Oncology Europe GmbH

Pharmaceutical Industry · Baar · Since 2021

The core activity of Taiho Oncology Europe GmbH is the development, manufacture and marketing of cancer medications and other pharmaceuticals, particularly in the fields of oncology, allergology and urology. The company focuses on researching and developing innovative cancer treatments and also offers consumer products for healthcare.

Takeda Pharmaceuticals International AG

Pharmaceutical Industry · Glattpark (Opfikon) · Since 2007

Takeda Pharmaceuticals International AG is the regional corporate office of Takeda and serves as the group's regional headquarters. It supports and represents the company’s pharmaceutical activities, including research and development, manufacturing and product distribution.

Tamarind GmbH

Naturopathic Clinics · Wettingen · Since 2001

The core activity of Tamarind GmbH is the manufacture and distribution of plant-based recipes, in particular products under the protected brands KNOWMORE and YUNNAN BAIYAO.

Tanimswiss Pharma GmbH

Management Consulting · Basel · Since 2024

The core activity of Tanimswiss Pharma GmbH is the development, manufacture and distribution of pharmaceutical generics, ayurvedic/herbal medicines, dietary supplements/nutraceuticals and medical devices. The company offers a wide range of products and focuses on improving patient health by providing access to affordable, high-quality medicines and medical devices.

TAP Pharmaceuticals AG

Pharmaceutical Industry · Baar · Since 2017

The core activity of Axarlabs/TaP Pharmaceuticals AG is the end-to-end development of pharmaceutical products, from formulation and process development to marketing. This also includes services such as clinical trials, regulatory strategies, analytics, intellectual property rights and quality management. The company also offers customized project management support and portfolio selection as well as commercial evaluation.

Target BioScience AG

Management Consulting · Rüschlikon · Since 2000

The core activity of Target BioScience AG is to provide services in the field of regulatory affairs for the pharmaceutical and biotechnology industry in Switzerland. This includes in particular: Regulatory Affairs: Submission and maintenance of marketing authorization for medicinal products with Swissmedic; Marketing Authorization Holding: Services as holder of the marketing authorization; Quality Management: Consulting and services in the field of quality management; RP Provision: Services as responsible person (Responsible Person); Market Access: Services in the field of market access and price setting. The company thus supports pharmaceutical and biotech companies in complying with regulatory requirements in Switzerland and helps them to bring and maintain their products on the market.

TargImmune Therapeutics AG

Research & Development · Basel · Since 2024

The core activity of TargImmune Therapeutics AG is the development and research of oncological compounds and the development of a modular, synthetic, targeted platform technology for nucleic acid therapy. In particular, the company focuses on the development of targeted apoptosis and immunomodulators (TAIMs) that use synthetic nanoparticles to deliver interchangeable nucleic acid therapeutics directly to the target. The goal is to selectively destroy cancer cells by mimicking natural processes.

Taysha Gene Therapies Switzerland GmbH

Pharmaceutical Industry · Basel · Since 2021

Taysha Gene Therapies Switzerland GmbH is a biopharmaceutical company focused on discovering, developing and commercializing gene therapies for monogenic diseases of the central nervous system (CNS). Its lead clinical program targets Rett syndrome (TSHA-102), an intrathecally delivered AAV9 gene replacement therapy that incorporates a miRNA‑responsive auto‑regulatory element (miRARE) to regulate MECP2 expression.

TECregen AG

Pharmaceutical Industry · Basel · Since 2023

TECregen AG develops, manufactures and distributes pharmaceutical and other healthcare products, and develops, holds and exploits related intellectual property rights.

Telix Pharmaceuticals (Switzerland) Sàrl

Pharmaceutical Industry · Petit-Lancy · Since 1999

The core activity of Telix Pharmaceuticals is the development and manufacture of biopharmaceutical products, in particular targeted radiation products for the diagnosis and treatment of cancer and rare diseases.

Teva Capital Services Switzerland, Zweigniederlassung der Teva Pharmaceuticals International GmbH

Pharmaceutical Industry · Jona · Since 2021

Teva Pharmaceuticals International GmbH

Pharmaceutical Industry · Jona · Since 2000

Teva Pharmaceuticals International GmbH is a pharmaceutical company that develops, manufactures and markets generic and biopharmaceutical medicines. Its operations include research and development across multiple therapeutic areas and global supply‑chain and production activities.

Therakles Pharmaceuticals AG

Research & Development · Baar · Since 2024

therainnova AG

Medical Technology Industry · Forch · Since 2021

The core activity of therainnova AG is the provision of strategic and operational consulting services in the field of regulatory affairs for companies in the biopharmaceutical industry in the EU and Switzerland. This includes, among other things: Consulting and support for regulatory procedures and applications, interactions with health authorities, management of submissions and approval applications, creation of orphan designations and pediatric plans, support for due diligence processes and M&A transactions, and interim management of regulatory affairs. The company thus offers a comprehensive range of services to support companies in the biopharmaceutical industry in navigating complex regulatory landscapes and bringing their products to market efficiently.

Theramex Switzerland GmbH

Pharmaceutical Industry · Zurich · Since 2017

Theramex Switzerland GmbH is a pharmaceutical company focused on women’s health, providing treatments and educational resources in areas such as contraception, menopause, osteoporosis and fertility.

Thermo Fisher Diagnostics AG

Pharmaceutical Industry · Reinach Bl · Since 2006

Thermo Fisher Diagnostics AG supplies diagnostic instruments, reagents, consumables, software and related services for clinical laboratories and life‑science research. Its portfolio includes laboratory equipment and analytical systems for sample and material characterization, chemical analysis and clinical diagnostics.

Thermo Fisher Scientific (Schweiz) AG

Pharmaceutical Industry · Reinach Bl · Since 2008

Thermo Fisher Scientific (Schweiz) AG supplies scientific instruments, reagents, consumables, software and services for research, diagnostics, biopharma and industrial laboratories. Its portfolio includes laboratory equipment, antibodies and assays, contract development and manufacturing (CDMO/CRO) services, instrument support and lab informatics solutions.

Tigen Pharma SA

Pharmaceutical Industry · Lausanne · Since 2017

The core activity of Tigen Pharma is the development and acceleration of access to new therapies in the field of cell and gene therapy, particularly for the treatment of cancer. The company combines scientific expertise, technological capabilities and a long-term perspective to develop innovative solutions for patients and society.

TILAB SWISS Sagl

Pharmaceutical Industry · Lugano · Since 2020

The company is primarily active in the manufacture of pharmaceutical products, dietary supplements and cosmetics. It offers a wide range of products, including magistral and official galenic preparations, capsules, ointments, emulsions, liquids, gels and other pharmaceutical forms. The company has a laboratory certified to ISO:9001 and equipped with state-of-the-art technologies and analytical instruments to perform qualitative and quantitative analyses. The company's core activity includes the development, manufacture and marketing of products for health, skin and personal care.

Torpedo Pharmaceuticals AG

Pharmaceutical Industry · Basel · Since 2021

The core activity of Torpedo Pharmaceuticals AG is the development of next-generation radiopharmaceuticals for the treatment of cancer.

Torqur AG

Pharmaceutical Industry · Basel · Since 2021

Torqur AG is a clinical-stage biotechnology company focused on the discovery and development of PI3K/mTOR inhibitors for cancer therapy. The company is developing a portfolio of dual PI3K/mTOR compounds, including the candidate bimiralisib (PQR309) formulated for oral and topical use, and is conducting clinical trials in oncology and dermatology indications.

Trias Pharma GmbH

Pharmaceutical Industry · Winterthur · Since 2017

The core activity of Trias Pharma GmbH is the development and manufacture of solid dosage forms, in particular oral dosage forms such as tablets and soft capsules, as well as the provision of analytical support services and expertise in the field of drug development, including the development of medical cannabis.

Trybol AG

Cosmetics Industry · Neuhausen Am Rheinfall · Since 1900

The core activity of Trybol AG is the manufacture, filling and packaging of cosmetics and toiletries. The company develops and markets its own recipes and branded products and also produces on a contract manufacturing and contract filling basis for other companies.

ufamed AG

Pharmaceutical Industry · Sursee · Since 1969

The core activity of ufamed AG is the development, manufacture and marketing of products for animal health and care, including biocidal products, dietary and supplementary feed, care products and veterinary medicinal products. The company also provides consulting services for animal owners and veterinarians.

Ultimate Medicine AG

Pharmaceutical Industry · Zurich · Since 2024

Ultimate Medicine AG develops small-molecule therapeutics targeting a novel toxic metabolite that disrupts neuronal functions and accelerates progression of Alzheimer's disease and other dementias. Its lead program is an oral small-molecule inhibitor designed to block metabolite synthesis and thereby reduce systemic and brain exposure through natural clearance mechanisms.

Ultragenyx Europe GmbH

Pharmaceutical Industry · Basel · Since 2024

Ultragenyx Europe GmbH is a biopharmaceutical company that develops therapies for rare and ultra-rare genetic diseases and researches multiple drug modalities, including gene therapy. The company maintains a clinical pipeline, provides approved medicines such as DOJOLVI and MEPSEVII, and operates patient support programs.

Unixis AG

Pharmaceutical Industry · Zofingen · Since 2022

Unixis AG provides CDMO services for pharmaceutical cannabis products, including product development, sourcing, manufacturing, packaging and market entry. The company holds Swissmedic licences for controlled substances and GDP approvals, conducts licensed import/export of THC flowers, and runs a cGMP pilot project to produce high‑purity THC distillate in partnership with Siegfried AG.

UR Health GmbH

Management Consulting · Marbach Lu · Since 2018

The core activity of UR Health GmbH is the commercialization of pharmaceutical products, particularly in the DACH region. The company offers services such as distribution, marketing and communication for pharmaceutical manufacturers to successfully place their products on the market. It has comprehensive knowledge of the pharmaceutical market, a broad network of partners and good personal contacts with decision-makers.

Urovant Sciences GmbH

Research & Development · Basel · Since 2024

Urovant Sciences GmbH is a pharmaceutical company focused on research, development and commercialization of therapies in urology, including treatments for overactive bladder such as Vibegron.

Ursapharm Schweiz GmbH

Pharmaceutical Industry · Hünenberg · Since 1998

The core activity of URSAPHARM is the development, manufacture and marketing of pharmaceutical products, in particular eye care products such as HYLO and EvoTears, as well as systems and manufacturing solutions for the pharmaceutical industry.

Vaccentis AG

Pharmaceutical Industry · Zurich · Since 2006

The core activity of Vaccentis AG is the development of tumor vaccines, particularly through the use of the individualized precision immunotherapy platform AIPI (ALL INDIVIDUALIZED PRECISION IMMUNOTHERAPY TUMOUR VACCINE TECHNOLOGY PLATFORM).

Vaderis Therapeutics AG

Research & Development · Basel · Since 2024

The core activity of Vaderis Therapeutics AG is the development of medications, particularly in the areas of rare diseases, nephrology, vascular diseases, fibrosis, anti-infectives, and immunology. The company focuses on the early clinical development of new molecules and has experience in collaborating with companies such as Novartis.

Valentis AG

Pharmaceutical Industry · Agno · Since 2017

The core activity of Valentis is the development, production and distribution of natural medical products, including dietary supplements, plant-based products, medical devices and liquid nutraceuticals, with a focus on nanotechnology. The company also offers contract manufacturing and private label production for other companies.

Valerius Biopharma AG

Pharmaceutical Industry · Reinach Bl · Since 2017

Valerius Biopharma AG develops biosimilars and manages a portfolio of orphan and non‑orphan candidates, conducting R&D on cell lines, process development and extensive analytical characterization.

VAMEDIS Swiss GmbH

Pharmaceutical Industry · Diepoldsau · Since 2006

Vandria SA

Pharmaceutical Industry · Epalinges · Since 2021

Vandria SA is a clinical-stage biotech company developing first-in-class small molecules against a novel metabolic target to restore mitochondrial function and reduce chronic inflammation for the treatment of age-related and chronic diseases. Its lead clinical CNS asset, VNA-318, is an orally available, brain-penetrant small molecule that completed Phase I studies demonstrating safety, tolerability and a pharmacokinetic profile suitable for once-daily oral dosing.

Vantive Health GmbH

Pharmaceutical Industry · Glattpark (Opfikon) · Since 2023

Vaximm AG

Pharmaceutical Industry · Basel · Since 2008

The core activity of VAXIMM is the development of oral T-cell immunotherapies for cancer patients.

VB Technochemicals SA

Pharmaceutical Industry · Chiasso · Since 1993

The core activity of VB Technochemicals SA encompasses the development, production and distribution of chemical and pharmaceutical products, particularly barium and zinc derivatives, as well as the manufacture of pharmaceutical solutions for various therapeutic areas. The company also provides distribution, marketing and regulatory services.